1 – 229 of 229
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
(
- Contribution to journal › Article
-
Mark
Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)
(
- Contribution to journal › Article
-
Mark
Health-related quality of life by type of breast surgery in women with primary breast cancer : prospective longitudinal cohort study
(
- Contribution to journal › Article
-
Mark
Preoperative prediction of nodal status using clinical data and artificial intelligence derived mammogram features enabling abstention of sentinel lymph node biopsy in breast cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
(
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
(
- Contribution to journal › Article
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
(
- Contribution to journal › Article
-
Mark
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
(
- Contribution to journal › Article
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
(
- Contribution to journal › Article
-
Mark
Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential
(
- Contribution to journal › Article
-
Mark
Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning : External Validation and Further Model Development
(
- Contribution to journal › Article
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
(
- Contribution to journal › Article
-
Mark
Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer : A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
(
- Contribution to journal › Article
- 2022
-
Mark
Prediction of node negative breast cancer and high disease burden through image analysis software on mammographic images and clinicopathological data
2022)(
- Contribution to conference › Abstract
-
Mark
The NILS Study Protocol : A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)
(
- Contribution to journal › Article
-
Mark
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
(
- Contribution to journal › Article
-
Mark
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
(
- Contribution to journal › Article
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
(
- Contribution to journal › Article
-
Mark
One-year recovery from breast cancer : Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
(
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications
(
- Contribution to journal › Article
-
Mark
St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer
(
- Contribution to journal › Article
-
Mark
Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer
(
- Contribution to journal › Article
-
Mark
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
(
- Contribution to journal › Article
-
Mark
Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data
(
- Contribution to journal › Article
-
Mark
Psychological resilience and health‐related quality of life in 418 swedish women with primary breast cancer : Results from a prospective longitudinal study
(
- Contribution to journal › Article
- 2020
-
Mark
Cosmetic outcome and symmetry for patients who have undergone bilateral therapeutic mammoplasty for breast cancer
(
- Contribution to journal › Article
-
Mark
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
(
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
(
- Contribution to journal › Article
-
Mark
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
(
- Contribution to journal › Article
-
Mark
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care
(
- Contribution to journal › Article
-
Mark
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up
(
- Contribution to journal › Article
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
(
- Contribution to journal › Article
-
Mark
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
(
- Contribution to journal › Article
-
Mark
Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression : a window-of-opportunity breast cancer trial
(
- Contribution to journal › Article
- 2019
-
Mark
Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial
(
- Contribution to journal › Article
-
Mark
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
(
- Contribution to journal › Article
-
Mark
Artificial neural network models to predict nodal status in clinically node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
(
- Contribution to journal › Article
-
Mark
Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations : effect of a prospective intervention in primary bladder cancer patients
(
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
(
- Contribution to journal › Article
-
Mark
Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence
(
- Contribution to journal › Article
- 2018
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
(
- Contribution to journal › Article
-
Mark
Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
(
- Contribution to journal › Published meeting abstract
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
(
- Contribution to journal › Article
-
Mark
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Stability of oestrogen and progesterone receptor antigenicity in formalin‐fixed paraffin‐embedded breast cancer tissue over time
(
- Contribution to journal › Article
-
Mark
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer
(
- Contribution to journal › Article
-
Mark
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer : A sub-study of RASTEN - A randomized trial with low molecular weight heparin
(
- Contribution to journal › Article
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
(
- Contribution to journal › Article
-
Mark
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
(
- Contribution to journal › Article
-
Mark
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
(
- Contribution to journal › Article
- 2017
-
Mark
Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013
(
- Contribution to journal › Article
-
Mark
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
(
- Contribution to journal › Article
-
Mark
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Quality of up to 35 years old archival breast cancer tissue in paraffinblocks for estrogen receptor evaluation
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch
(
- Contribution to journal › Article
-
Mark
Nomograms for preoperative prediction of axillary nodal status in breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer : the Danish cohort of BIG 1-98
(
- Contribution to journal › Article
-
Mark
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
(
- Contribution to journal › Article
-
Mark
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
(
- Contribution to journal › Article
-
Mark
Modelling pulmonary microthrombosis coupled to metastasis : Distinct effects of thrombogenesis on tumorigenesis
(
- Contribution to journal › Article
-
Mark
AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
(
- Contribution to conference › Abstract
-
Mark
Quality of up to 35 years old archival breast cancer tissue in paraffin-blocks for estrogen receptor evaluation
(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.
(
- Contribution to journal › Article
-
Mark
St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
(
- Contribution to journal › Article
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
-
Mark
Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
(
- Contribution to journal › Article
-
Mark
The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology
(
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen provides a survival benefit compared with no systemic treatment in premenopausal patients with primary breast cancer : Long-Term follow-up (> 25 years) of the phase III SBII:2pre trial
(
- Contribution to journal › Article
- 2015
-
Mark
Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.
(
- Contribution to journal › Article
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.
(
- Contribution to journal › Article
-
Mark
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
(
- Contribution to journal › Article
-
Mark
Global transcriptional changes following statin treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
-
Mark
Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013
(
- Contribution to journal › Published meeting abstract
-
Mark
Whole genome sequencing of primary breast cancers and matched distant metastases
2015) American Association for Cancer Research (AACR) 106th Annual Meeting 2015 In Cancer Research 75(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
(
- Contribution to journal › Article
- 2014
-
Mark
A novel model for Ki67 assessment in breast cancer.
(
- Contribution to journal › Article
-
Mark
The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
(
- Contribution to journal › Article
-
Mark
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
(
- Contribution to journal › Article
-
Mark
The role of histological grade in discrimination between Luminal A-like and Luminal B-like subtypes in a series of premenopausal breast cancer patients
2014) 26th European Congress of Pathology In Virchows Archiv: an international journal of pathology 465(Supplement 1). p.123-123(
- Contribution to journal › Published meeting abstract
-
Mark
71p * statin-induced anti-proliferative effects via cyclin d1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.
(
- Contribution to journal › Article
-
Mark
Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor.
(
- Contribution to journal › Article
-
Mark
Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.
(
- Contribution to journal › Published meeting abstract
-
Mark
A Prognostic Index Composed of Progesterone Receptor Status, Tumour Size and S-phase Fraction, Predicts Survival in Node-Negative Breast Cancer Patients in a Large Multicentre Prospective Cohort Study.
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
(
- Contribution to journal › Article
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
(
- Contribution to journal › Article
-
Mark
The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
(
- Contribution to journal › Article
-
Mark
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
(
- Contribution to journal › Article
-
Mark
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
(
- Contribution to journal › Article
-
Mark
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
(
- Contribution to journal › Article
-
Mark
Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol
(
- Contribution to journal › Article
-
Mark
Training artificial neural networks directly on the concordance index for censored data using genetic algorithms.
(
- Contribution to journal › Article
-
Mark
Efficient and reproducible identification of mismatch repair deficient colon cancer : Validation of the MMR index and comparison with other predictive models
(
- Contribution to journal › Article
- 2012
-
Mark
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
(
- Contribution to journal › Article
-
Mark
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
(
- Contribution to journal › Article
-
Mark
Ezrin expression in rectal cancer predicts time to development of local recurrence
(
- Contribution to journal › Article
-
Mark
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
(
- Contribution to journal › Article
-
Mark
Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
2012) In Human Pathology(
- Contribution to journal › Article
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
(
- Contribution to journal › Article
-
Mark
A Plea for Surgical Lymph Node Staging in Advanced Prostate Cancer.
2012) In European Urology(
- Contribution to journal › Letter
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
-
Mark
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
(
- Contribution to journal › Article
-
Mark
Validation of a Self-Concept Scale for Lynch Syndrome in Different Nationalities
(
- Contribution to journal › Article
-
Mark
Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
(
- Contribution to journal › Article
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer.
(
- Contribution to journal › Article
-
Mark
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
2011) In BJU International(
- Contribution to journal › Article
-
Mark
A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern.
(
- Contribution to journal › Article
-
Mark
Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates.
(
- Contribution to journal › Article
-
Mark
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
(
- Contribution to journal › Article
-
Mark
P4-09-02: G Protein-Coupled Estrogen Receptor 1 Positively Correlates with Estrogen Receptor a Expression and Increased Distant Disease-Free Survival of Breast Cancer Patients.
(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Three different antibodies for estrogen receptor analysis in breast cancer - implications for positive frequency, reproducibility and clinical outcome
(
- Contribution to journal › Published meeting abstract
-
Mark
Ki67 proliferation as a biomarker in neo-adjuvant breast cancer studies - core biopsy versus surgical sample
(
- Contribution to journal › Published meeting abstract
-
Mark
Ki-67 as a long-term prognostic factor in lobular breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
(
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
(
- Contribution to journal › Article
-
Mark
Adjuvant radiotherapy of women with breast cancer - Information, support and side-effects.
(
- Contribution to journal › Article
-
Mark
Tensile Strength of Surgical Knots Performed with the da Vinci Surgical Robot.
(
- Contribution to journal › Article
-
Mark
AIB1 is a predictive factor for tamoxifen response in premenopausal women.
(
- Contribution to journal › Article
-
Mark
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
2010) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 23. p.251-259(
- Contribution to journal › Article
-
Mark
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1.
(
- Contribution to journal › Article
-
Mark
Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?
(
- Contribution to journal › Article
-
Mark
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
(
- Contribution to journal › Article
-
Mark
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
(
- Contribution to journal › Article
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
(
- Contribution to journal › Published meeting abstract
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels
(
- Contribution to journal › Article
-
Mark
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
(
- Contribution to journal › Article
-
Mark
An effect from anticipation also in hereditary nonpolyposis colorectal cancer families without identified mutations
(
- Contribution to journal › Article
-
Mark
EXTENDED LYMPH NODE DISSECTION IN PATIENTS WITH UROTHELIAL CELL CARCINOMA OF THE BLADDER: CAN IT MAKE A DIFFERENCE?
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.256-256(
- Contribution to journal › Published meeting abstract
-
Mark
Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Is the prognostic value of Ki-67 dependent on ER status and histological grade?
(
- Contribution to journal › Published meeting abstract
-
Mark
Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
(
- Contribution to journal › Article
-
Mark
Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer - A national survey performed at pathology departments in Sweden.
(
- Contribution to journal › Article
-
Mark
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
(
- Contribution to journal › Article
-
Mark
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
(
- Contribution to journal › Article
-
Mark
Should All Patients with Non-Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study.
(
- Contribution to journal › Article
- 2008
-
Mark
Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer
(
- Contribution to journal › Article
-
Mark
Characterization Of Non-Small Cell Lung Cancer Using Tiling Resolution Bacterial Artificial Chromosome Microarrays
(
- Contribution to journal › Published meeting abstract
-
Mark
Egfr Amplifications And Mutations In Lung Cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Epidermal Growth Factor Receptor (EGFR) in primary breast cancer-protein expression, but not gene copy number, gives important prognostic information in tamoxifen treated patients
2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.187-187(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer
(
- Contribution to journal › Article
-
Mark
Early intravesical epirubicin instillation after transurethral resection for non-muscle invasive bladder cancer is inefficient for recurrent tumours
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.177-177(
- Contribution to journal › Published meeting abstract
-
Mark
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
(
- Contribution to journal › Article
-
Mark
Analys av HER2 i bröstcancer kvalitetssäkrad. Viktig behandlingsprediktiv och prognostisk faktor.
(
- Contribution to journal › Article
-
Mark
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
-
Mark
High amplified in breast cancer 1 is a significant predictor of improved response to adjuvant tamoxifen in premenopausal women
2008) 31st Annual San Antonio Breast Cancer Symposium(
- Contribution to conference › Abstract
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
- 2007
-
Mark
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
(
- Contribution to journal › Article
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
(
- Contribution to journal › Article
-
Mark
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor - Positive premenopausal breast cancer
(
- Contribution to journal › Article
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
-
Mark
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
(
- Contribution to journal › Article
-
Mark
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
(
- Contribution to journal › Article
-
Mark
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
- 2006
-
Mark
Focus on the tumor periphery in MRI evaluation of soft tissue sarcoma: infiltrative growth signifies poor prognosis
(
- Contribution to journal › Article
-
Mark
Benefits from membership in cancer patient associations: Relations to gender and involvement.
(
- Contribution to journal › Article
- 2005
-
Mark
Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
(
- Contribution to journal › Article
-
Mark
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
(
- Contribution to journal › Article
-
Mark
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
(
- Contribution to journal › Article
-
Mark
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
(
- Contribution to journal › Article
-
Mark
Estrogen receptor (ER)-beta has favorable independent prognostic value for ER-alfa negative breast cancer patients receiving adjuvant tamoxifen
(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
(
- Contribution to journal › Article
-
Mark
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study
(
- Contribution to journal › Article
-
Mark
Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
-
Mark
Blood pharmacokinetics of various mabs labeled with a new tri-chelating reagent for simultaneous conjugation with DOTA and biotin prior to radiolabeling
2004) 10th Conference on Cancer Therapy with Antibodies and Immunoconjugates In Cancer Biotherapy and Radiopharmaceuticals 19(4). p.540-541(
- Contribution to journal › Published meeting abstract
-
Mark
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
(
- Contribution to journal › Article
- 2003
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
-
Mark
A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)
(
- Contribution to journal › Article
-
Mark
Low-dose hormone therapy and carbohydrate metabolism.
(
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
-
Mark
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines
(
- Contribution to journal › Article
-
Mark
Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer - Clinical associations and reasons for discrepancies
(
- Contribution to journal › Article
-
Mark
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
(
- Contribution to journal › Article
-
Mark
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
(
- Contribution to journal › Article
- 2002
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis
(
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
(
- Contribution to journal › Article
-
Mark
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
(
- Contribution to journal › Article
-
Mark
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
(
- Contribution to journal › Article
-
Mark
Validering av ny prognostisk modell i lymfkörtelnegativ bröstcancer baserad på automatiskt utvärderade DNA flödescytometriska data
2002) Svenska Läkaresällskapets Riksstämma(
- Contribution to conference › Poster
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
(
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
(
- Contribution to journal › Article
-
Mark
DNA and cell cycle analysis as prognostic indicators in breast tumors revisited
(
- Contribution to journal › Article
-
Mark
Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens
(
- Contribution to journal › Article
-
Mark
Image cytometric Auer class-I identifies a real low risk group among lymph node negative premenopausal breast cancer patients
(
- Contribution to journal › Published meeting abstract
-
Mark
Histological grade, its three components and flow cytometric S-phase as prognostic markers in premenopausal women with node negative breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase) : association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients
(
- Contribution to journal › Article
- 2000
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
-
Mark
Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
- 1999
-
Mark
No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
(
- Contribution to journal › Published meeting abstract
- 1998
-
Mark
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
(
- Contribution to journal › Article
-
Mark
Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
(
- Contribution to journal › Published meeting abstract
- 1997
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article
-
Mark
Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group
(
- Contribution to journal › Article
- 1996
-
Mark
Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates
(
- Contribution to journal › Article
- 1994
-
Mark
An improved mathematical method to estimate DNA synthesis time of bromodeoxyuridine-labelled cells, using FCM-derived data
(
- Contribution to journal › Article